Transdel Pharmaceuticals, Inc.
4225 Executive Square
Suite 460
La Jolla
California
92037
United States
Tel: 858-457-5300
Website: http://www.transdelpharma.com/
Email: Info@transdelpharma.com
39 articles about Transdel Pharmaceuticals, Inc.
-
Transdel Pharmaceuticals, Inc. Files for Chapter 11, Agrees to Sell Lead Drug Candidate to Cardium Therapeutics, Inc.
6/28/2011
-
Transdel Pharmaceuticals, Inc. Announces Exploration of Strategic Alternatives
2/1/2011
-
Transdel Pharmaceuticals, Inc. Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President
10/21/2010
-
Transdel Pharmaceuticals, Inc. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
9/7/2010
-
Transdel Pharmaceuticals, Inc. Presents Phase 3 Study Data on Ketotransdel(R) at World Pain Congress in Montreal, Canada
9/2/2010
-
Transdel Pharmaceuticals, Inc. Reports Second Quarter and Year-to-Date 2010 Results
8/12/2010
-
Transdel Pharmaceuticals, Inc. to Present at 2010 Southern California Investor Conference
8/11/2010
-
Transdel Pharmaceuticals, Inc. to Present at OneMedForum New York 2010
6/24/2010
-
Transdel Pharmaceuticals, Inc. Reports First Quarter 2010 Results
5/13/2010
-
Data from Transdel Pharmaceuticals, Inc.'s Phase 3 Study to be Presented at 13th World Congress on Pain
5/4/2010
-
Transdel Pharmaceuticals, Inc. Closes $1 Million Debt Financing
4/8/2010
-
Transdel Pharmaceuticals, Inc. Appoints Terry Nida as Chief Business Officer
3/1/2010
-
Transdel Pharmaceuticals, Inc. Announces Dr. Juliet Singh Resigns as President and Chief Executive Officer
2/18/2010
-
Transdel Pharmaceuticals, Inc. to Present at Two Investor Conferences
10/20/2009
-
Transdel Pharmaceuticals, Inc. Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
10/13/2009
-
Transdel Pharmaceuticals, Inc. Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
10/6/2009
-
Transdel Pharmaceuticals, Inc. to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
10/5/2009
-
Transdel Pharmaceuticals, Inc. to Present at Thomas Weisel Partners Healthcare Conference
9/2/2009
-
Transdel Pharmaceuticals, Inc. Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment
7/8/2009
-
Transdel Pharmaceuticals, Inc. Provides Update on Timing of Results for Phase 3 Study
6/15/2009